Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
D000008:Abdominal Neoplasms / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000188:drug therapy; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D005153:Facial Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009360:Neoplastic Cells, Circulating; D012075:Remission, Spontaneous; D013899:Thoracic Neoplasms / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage* / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate